دسترسی یکساله به بیش از ۵۰۰ ژورنال روز جهان موجود در سامانه
-
http://medilib.ir
- ﻣﺪﺕ ﺯﻣﺎﻥ : 365 ﺭﻭﺯ
قیمت : 3,800,000 تومان- قیمت ویژه : 1,900,000تومان
Unusual Presentation of a Pedunculated Lipoma
Daniel Kats,Jennifer Liu-Burdowski,Haroon Shahid
doi : 10.1016/j.cgh.2019.09.047
Volume 19, ISSUE 1, e1, January 01, 2021
What in the World Is This? A Large Oral Mass Seen During Endoscopy
Manoop S. Bhutani
doi : 10.1016/j.cgh.2019.10.015
Volume 19, ISSUE 1, e2, January 01, 2021
Neurofibromatosis Type 1-Associated Gastrointestinal Stromal Tumor
Shelini Sooklal,Hassan Siddiki
doi : 10.1016/j.cgh.2019.10.026
Volume 19, ISSUE 1, e3-e4, January 01, 2021
IgA Vasculitis of the Skin and Small Bowel in an Adult Patient
Maran Fazzi,Anton R. Romeijn,Rinze W.F. ter Steege
doi : 10.1016/j.cgh.2019.10.027
Volume 19, ISSUE 1, e5, January 01, 2021
Nothing but NET: A Case of Neuroendocrine Tumor in the Duodenal Bulb
Michelle Baliss,Mohammad Bilal,Sheharyar Merwat
doi : 10.1016/j.cgh.2019.10.037
Volume 19, ISSUE 1, e6, January 01, 2021
Issue Highlights
Jane Onken, MD
doi : 10.1016/j.cgh.2020.11.013
Volume 19, ISSUE 1, P1-4, January 01, 2021
Educator and Trainee Perspectives Introduction
Jane Onken, MD
doi : 10.1016/j.cgh.2020.10.047
Volume 19, ISSUE 1, P5, January 01, 2021
C.O.V.I.D.: A Survival Guide for GI Fellowship Training During the COVID-19 Pandemic
Tzu-Hao Lee,Cecelia Zhang,Richard Wood, Darshan Kothari
doi : 10.1016/j.cgh.2020.10.001
Volume 19, ISSUE 1, P6-9, January 01, 2021
Dissecting Drug Pricing in Gastroenterology and Hepatology
Amy N. Thompson,Shirley Cohen-Mekelburg,Marianne Udow-Philllips,Chester B. Good,Akbar K. Waljee
doi : 10.1016/j.cgh.2020.07.057
Volume 19, ISSUE 1, P10-13.e1, January 01, 2021
Endoscopic Diagnosis and Management of Gastrointestinal Trauma
Robert J. Sealock,Mohamed Othman,Koushik Das
doi : 10.1016/j.cgh.2019.09.048
Volume 19, ISSUE 1, P14-23, January 01, 2021
Interventional Endoscopic Ultrasound: Current Status and Future Directions
John M. DeWitt,Mustafa Arain,Kenneth J. Chang,...V. Raman Muthusamy,Joo Ha Hwangon behalf of the AGA Center for GI Innovation and Technology
doi : 10.1016/j.cgh.2020.09.029
Volume 19, ISSUE 1, P24-40, January 01, 2021
Leaving No Stone Unturned in the Search for Adverse Events Associated With Use of Proton Pump Inhibitors
Paul Moayyedi
doi : 10.1016/j.cgh.2020.04.053
Volume 19, ISSUE 1, P41-42, January 01, 2021
Health Economic Studies Are Important for Patients With Irritable Bowel Syndrome and Their Gastroenterologists
Eric D. Shah, Sarah K. Ballou
doi : 10.1016/j.cgh.2020.05.022
Volume 19, ISSUE 1, P43-45, January 01, 2021
Hepatitis B Core-Related Antigen to Indicate High Viral Load: Systematic Review and Meta-Analysis of 10,397 Individual Participants
Kyoko Yoshida,Alice Desbiolles,Sarah F. Feldman,...Maud Lemoine,Yasuhito Tanaka,Yusuke Shimakawa
doi : 10.1016/j.cgh.2020.04.045
Volume 19, ISSUE 1, P46-60.e8, January 01, 2021
To eliminate hepatitis B virus (HBV) infection, scale-up of testing and treatment in resource-limited countries is crucial. However, access to nucleic acid testing to quantify HBV DNA, an essential test to examine treatment eligibility, remains severely limited. We assessed the performance of a novel immunoassay, HBV core-related antigen (HBcrAg), as a low-cost (less than US $15/assay) alternative to nucleic acid testing to indicate clinically important high viremia in chronic HBV patients infected with different genotypes.
Women Have a Lower Risk of Nonalcoholic Fatty Liver Disease but a Higher Risk of Progression vs Men: A Systematic Review and Meta-analysis
Maya Balakrishnan,Parth Patel,Sydney Dunn-Valadez,...Yan Liu,Hashem B. El-Serag,Fasiha Kanwal
doi : 10.1016/j.cgh.2020.04.067
Volume 19, ISSUE 1, P61-71.e15, January 01, 2021
The risk of nonalcoholic fatty liver disease (NAFLD) and its progression may differ between men and women. We conducted a systematic review and meta-analysis to determine the relationship between sex and NAFLD, nonalcoholic steatohepatitis (NASH), and advanced NAFLD fibrosis.
Use of Proton Pump Inhibitors Increases Risk of Incident Kidney Stones
Michael Simonov,Erica A. Abel,Melissa Skanderson,...Cynthia A. Brandt,Francis P. Wilson,Loren Laine
doi : 10.1016/j.cgh.2020.02.053
Volume 19, ISSUE 1, P72-79.e21, January 01, 2021
Proton pump inhibitors (PPIs) are widely prescribed and have effects on gut ion absorption and urinary ion concentrations. PPIs might therefore protect against or contribute to development of kidney stones. We investigated the association between PPI use and kidney stones.
Patients With Irritable Bowel Syndrome Are Willing to Take Substantial Medication Risks for Symptom Relief
Shawn L. Shah,Nigeen H. Janisch,Michael Crowell,Brian E. Lacy
doi : 10.1016/j.cgh.2020.04.003
Volume 19, ISSUE 1, P80-86, January 01, 2021
Irritable bowel syndrome (IBS) is a common chronic functional bowel disorder for which patients take significant risks to ameliorate symptoms. Unfortunately, there is no cure for IBS. We assessed the willingness of patients with IBS to take medication risks and the costs they would pay to improve symptoms.
Healthy Lifestyle Is Associated With Reduced Mortality in Patients With Inflammatory Bowel Diseases
Chun-Han Lo,Hamed Khalili,Mingyang Song,...Edward L. Giovannucci,Andrew T. Chan,Ashwin N. Ananthakrishnan
doi : 10.1016/j.cgh.2020.02.047
Volume 19, ISSUE 1, P87-95.e4, January 01, 2021
It is not clear whether a healthy lifestyle affects mortality of patients with inflammatory bowel diseases (IBD), including Crohn’s disease (CD) and ulcerative colitis (UC).
Integrated Psychological Care Reduces Health Care Costs at a Hospital-Based Inflammatory Bowel Disease Service
Taryn Lores,Charlotte Goess,Antonina Mikocka-Walus,...Anna Chur-Hansen,Paul Delfabbro,Jane M. Andrews
doi : 10.1016/j.cgh.2020.01.030
Volume 19, ISSUE 1, P96-103.e3, January 01, 2021
Inflammatory bowel diseases (IBD) are associated with high psychosocial burden and economic cost. Integrating psychological care into routine management might lead to savings. We performed a 2-year investigation of the effects of integrated psychological care in reducing healthcare use and costs.
Effectiveness of Ustekinumab Dose Escalation in Patients With Crohn’s Disease
Jacob E. Ollech,Inessa Normatov,Noam Peleg,...Russell D. Cohen,David T. Rubin,Joel Pekow
doi : 10.1016/j.cgh.2020.02.035
Volume 19, ISSUE 1, P104-110, January 01, 2021
A subset of patients with Crohn’s disease (CD) do not respond to ustekinumab at the standard dose of 90 mg every 8 weeks. Little is known about the efficacy of shortening the interval between doses.
Peak Concentrations of Ustekinumab After Intravenous Induction Therapy Identify Patients With Crohn’s Disease Likely to Achieve Endoscopic and Biochemical Remission
Jurij Han?el,Jurij Zdovc,Tina Kurent,...Toma? Vovk,Iztok Grabnar,David Drobne
doi : 10.1016/j.cgh.2020.02.033
Volume 19, ISSUE 1, P111-118.e10, January 01, 2021
Little is known about the relationship between ustekinumab exposure during the first 2 weeks of treatment and outcomes of patients with Crohn’s disease (CD). We investigated the relationship between serum concentrations of ustekinumab during the first 2 weeks of treatment and endoscopic and biochemical remission in patients with CD.
Development and Validation of the Asia-Pacific Proximal Colon Neoplasia Risk Score
Martin C.S. Wong,Rungsun Rerknimitr,Khean Lee Goh,...Jingnan Li,Jessica Y.L. Ching,Joseph J.Y. Sung
doi : 10.1016/j.cgh.2019.12.031
Volume 19, ISSUE 1, P119-127.e1, January 01, 2021
Patients found to be at high risk of advanced proximal neoplasia (APN) after flexible sigmoidoscopy screening should be considered for colonoscopy examination. We developed and validated a scoring system to identify persons at risk for APN.
No Association Between Vitamin D Supplementation and Risk of Colorectal Adenomas or Serrated Polyps in a Randomized Trial
Mingyang Song,I-Min Lee,JoAnn E. Manson,...Charles S. Fuchs,Jeffrey A. Meyerhardt,Edward L. Giovannucci
doi : 10.1016/j.cgh.2020.02.013
Volume 19, ISSUE 1, P128-135.e6, January 01, 2021
The effects of vitamin D on risk of colorectal cancer precursors are not clear. We examined the influence of vitamin D supplementation on risk of colorectal adenomas and serrated polyps in a prespecified ancillary study of a large-scale prevention trial (the vitamin D and omegA-3 trial, VITAL) of individuals who were free of cancer and cardiovascular disease at enrollment.
Type 2 Diabetes and Metformin Use Associate With Outcomes of Patients With Nonalcoholic Steatohepatitis–Related, Child–Pugh A Cirrhosis
Eduardo Vilar-Gomez,Luis Calzadilla-Bertot,Vincent Wai-Sun Wong,...Jacob George,Manuel Romero-Gomez,Leon A. Adams
doi : 10.1016/j.cgh.2020.04.083
Volume 19, ISSUE 1, P136-145.e6, January 01, 2021
Factors that affect outcomes of patients with nonalcoholic steatohepatitis (NASH)-related cirrhosis are unclear. We studied associations of type 2 diabetes, levels of hemoglobin A1c (HbA1c), and use of antidiabetic medications with survival and liver-related events in patients with NASH and compensated cirrhosis.
Intragastric Balloon Placement Induces Significant Metabolic and Histologic Improvement in Patients With Nonalcoholic Steatohepatitis
Fateh Bazerbachi,Eric J. Vargas,Monika Rizk,...Andrew C. Storm,Michael J. Levy,Barham K. Abu Dayyeh
doi : 10.1016/j.cgh.2020.04.068
Volume 19, ISSUE 1, P146-154.e4, January 01, 2021
Obese patients with nonalcoholic steatohepatitis (NASH) are at risk for cirrhosis if significant weight loss is not achieved. The single fluid-filled intragastric balloon (IGB) induces meaningful weight loss and might be used in NASH treatment. We performed an open-label prospective study to evaluate the effects of IGB placement on metabolic and histologic features of NASH.
Physical and Mental Quality of Life in Patients With End-Stage Liver Disease and Their Informal Caregivers
Lissi Hansen,Michael F. Chang,Christopher S. Lee,...Evan J. Firsick,Nathan F. Dieckmann,Karen S. Lyons
doi : 10.1016/j.cgh.2020.04.014
Volume 19, ISSUE 1, P155-161.e1, January 01, 2021
Management of end-stage liver disease (ESLD) has implications for not only patients’ quality of life (QOL), but also their caregivers’. We aimed to identify characteristics of patients with ESLD and their caregivers that are associated with QOL.
Serum Levels of ?-Fetoprotein Increased More Than 10 Years Before Detection of Hepatocellular Carcinoma
David M. Hughes,Sarah Berhane,C.A. Emily de Groot,...Tom Bird,Marta Garc?a-Fi?ana,Philip Johnson
doi : 10.1016/j.cgh.2020.04.084
Volume 19, ISSUE 1, P162-170.e4, January 01, 2021
Ultrasound (US)-based screening has been recommended for patients with an increased risk of hepatocellular carcinoma (HCC). US analysis, however, is limited in patients who are obese or have small tumors. The addition of serum level of ?-fetoprotein (AFP) measurements to US analysis can increase detection of HCC. We analyzed data from patients with chronic liver disease, collected over 15 years in an HCC surveillance program, to develop a model to assess risk of HCC.
Diabetes and Weight Loss Are Associated With Malignancies in Patients With Intraductal Papillary Mucinous Neoplasms
Ilaria Pergolini,Carsten J?ger,Okan Safak,...Güralp O. Ceyhan,Helmut Friess,Ihsan Ekin Demir
doi : 10.1016/j.cgh.2020.04.090
Volume 19, ISSUE 1, P171-179, January 01, 2021
The role of diabetes in intraductal papillary mucinous neoplasms (IPMNs) is not known. We investigated the prevalence of diabetes among patients with resected IPMNs and the association between diabetes, clinical and morphological features, and high-grade dysplasia or invasive cancer.
Nurse-Administered Propofol Continuous Infusion Sedation for Gastrointestinal Endoscopy in Patients Who Are Difficult to Sedate
Hyun Seok Lee,Navroop Nagra,Danielle La Selva,...Rajesh Krishnamoorthi,Michael Larsen,Otto S. Lin
doi : 10.1016/j.cgh.2020.09.018
Volume 19, ISSUE 1, P180-188, January 01, 2021
Patients who chronically use alcohol, marijuana, or opioids, or suffer from post-traumatic stress disorder (PTSD), can be difficult to sedate with midazolam and fentanyl, and often are referred for monitored anesthesia care during endoscopy. Nurse-administered propofol continuous infusion sedation (NAPCIS), which confers the benefit of propofol-based sedation without the added expense of anesthesia, is effective and safe for sedation of healthy patients. We investigated whether NAPCIS also is effective for patients who are difficult to sedate.
Surveillance Endoscopy in the Management of Hereditary Diffuse Gastric Cancer Syndrome
Madeline Friedman,Tomer Adar,Devanshi Patel,...Sam S. Yoon,John T. Mullen,Daniel C. Chung
doi : 10.1016/j.cgh.2019.10.033
Volume 19, ISSUE 1, P189-191, January 01, 2021
Is Colorectal Cancer in Patients Younger Than 50 Years of Age the Same Disease as in Older Patients?
Pooja Dharwadkar,Garrett Greenan,Amit G. Singal,Caitlin C. Murphy
doi : 10.1016/j.cgh.2019.10.028
Volume 19, ISSUE 1, P192-194.e3, January 01, 2021
Efficacy of Retreatment After Failed Direct-acting Antiviral Therapy in Patients With HCV Genotype 1–3 Infections
Julia Dietz,Ulrich Spengler,Beat Müllhaupt,...Johannes Vermehren,Christoph Sarrazinfor the European HCV Resistance Study Group
doi : 10.1016/j.cgh.2019.10.051
Volume 19, ISSUE 1, P195-198.e2, January 01, 2021
Identifying Patients With Cirrhosis Who Might Avoid Screening Endoscopy Based on Serum Albumin and Bilirubin and Platelet Counts
Guan Sen Kew,Zhao Jin Chen,Alexander Wenjun Yip,...Mark Dinesh Muthiah,Bee Choo Tai,Poh Seng Tan
doi : 10.1016/j.cgh.2019.11.015
Volume 19, ISSUE 1, P199-201.e2, January 01, 2021
Association Between Polyp Detection Rate and Post-Colonoscopy Cancer Among Patients Undergoing Diagnostic Colonoscopy
Rachel Gingold-Belfer,Doron Boltin,Orly Sneh-Arbib,...Lital Boker Keinan,Iris Dotan,Zohar Levi
doi : 10.1016/j.cgh.2019.11.016
Volume 19, ISSUE 1, P202-204, January 01, 2021
Exam 1: Women Have a Lower Risk of Nonalcoholic Fatty Liver Disease but a Higher Risk of Progression vs Men: A Systematic Review and Meta-analysis
doi : 10.1016/j.cgh.2020.11.014
Volume 19, ISSUE 1, e7-e8, January 01, 2021
Inflammatory Bowel Disease Patients With Coronavirus Disease 2019: The Picture Is Taking Shape
Alfredo Papa, Loris Riccardo Lopetuso, Antonio Tursi
doi : 10.1016/j.cgh.2020.08.033
Volume 19, ISSUE 1, P205-206, January 01, 2021
Lessons From COVID-19, ACE2, and Intestinal Inflammation: Could a Virus Trigger Chronic Intestinal Inflammation?
Timothy P. Hanrahan, John S. Lubel, Mayur Garg
doi : 10.1016/j.cgh.2020.07.036
Volume 19, ISSUE 1, P206, January 01, 2021
Cost-effectiveness of Telemedicine-directed Specialized vs Standard Care for Patients With Inflammatory Bowel Diseases in a Randomized Trial
Javier Del Hoyo, Mariam Aguas
doi : 10.1016/j.cgh.2020.06.016
Volume 19, ISSUE 1, P206-207, January 01, 2021
Risk Factors of Diverticulitis With Special Reference to Inflammation
Tomoyuki Kawada, MD
doi : 10.1016/j.cgh.2020.02.040
Volume 19, ISSUE 1, P207-208, January 01, 2021
Reply
Wenjie Ma, Lisa L. Strate, Andrew T. Chan
doi : 10.1016/j.cgh.2020.03.021
Volume 19, ISSUE 1, P208-209, January 01, 2021
Two Types of Fecal Tests in Patients With Ulcerative Colitis
Cong Dai,Yu-Hong Huang,Min Jiang
doi : 10.1016/j.cgh.2019.08.059
Volume 19, ISSUE 1, P209, January 01, 2021
Reply
Makoto Naganuma, Takanori Kanai
doi : 10.1016/j.cgh.2019.09.015
Volume 19, ISSUE 1, P209-210, January 01, 2021
Working Together to Meet the Needs of Patients With Inflammatory Bowel Diseases
Erica J. Brenner,Michael D. Kappelman
doi : 10.1016/j.cgh.2020.03.055
Volume 19, ISSUE 1, P210-211, January 01, 2021
Elsewhere in the AGA Journals
doi : 10.1016/S1542-3565(20)31570-6
Volume 19, ISSUE 1, PA11-A13, January 01, 2021
Information for Authors and Readers
doi : 10.1016/S1542-3565(20)31571-8
Volume 19, ISSUE 1, PA15-A16, January 01, 2021
AIDS-associated Esophageal Plasmablastic Lymphoma
Hamza M. Abdulla,Steven Cohn
doi : 10.1016/j.cgh.2019.12.027
Volume 19, ISSUE 1, PA18, January 01, 2021
A Cutaneous Clue to a Tropical Cause of Acute Pancreatitis: Scrub Typhus
Deepak James,Vishal Sharma
doi : 10.1016/j.cgh.2019.12.037
Volume 19, ISSUE 1, PA19, January 01, 2021
Massive Lower Gastrointestinal Bleeding Due to Cytomegalovirus-Related Ileal Ulcer
Puru Rattan Ryan Cristelli Anish Vinit Patel
doi : 10.1016/j.cgh.2020.01.015
Volume 19, ISSUE 1, PA20, January 01, 2021
